Prion neurotoxicity

Brain Pathol. 2019 Mar;29(2):263-277. doi: 10.1111/bpa.12694. Epub 2019 Jan 17.

Abstract

Although the mechanisms underlying prion propagation and infectivity are now well established, the processes accounting for prion toxicity and pathogenesis have remained mysterious. These processes are of enormous clinical relevance as they hold the key to identification of new molecular targets for therapeutic intervention. In this review, we will discuss two broad areas of investigation relevant to understanding prion neurotoxicity. The first is the use of in vitro experimental systems that model key events in prion pathogenesis. In this context, we will describe a hippocampal neuronal culture system we developed that reproduces the earliest pathological alterations in synaptic morphology and function in response to PrPSc . This system has allowed us to define a core synaptotoxic signaling pathway involving the activation of NMDA and AMPA receptors, stimulation of p38 MAPK phosphorylation and collapse of the actin cytoskeleton in dendritic spines. The second area concerns a striking and unexpected phenomenon in which certain structural manipulations of the PrPC molecule itself, including introduction of N-terminal deletion mutations or binding of antibodies to C-terminal epitopes, unleash powerful toxic effects in cultured cells and transgenic mice. We will describe our studies of this phenomenon, which led to the recognition that it is related to the induction of large, abnormal ionic currents by the structurally altered PrP molecules. Our results suggest a model in which the flexible N-terminal domain of PrPC serves as a toxic effector which is regulated by intramolecular interactions with the globular C-terminal domain. Taken together, these two areas of study have provided important clues to underlying cellular and molecular mechanisms of prion neurotoxicity. Nevertheless, much remains to be done on this next frontier of prion science.

Keywords: antibody; cell culture; dendrite; glutamate; ionic current; mitogen-activated protein kinase (MAPK); neurodegeneration; neurotoxicity; prion; spine; synapse; transgenic mouse.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Brain / pathology
  • Cell Line
  • Cells, Cultured
  • Dendritic Spines / pathology
  • Hippocampus / pathology
  • Humans
  • N-Methylaspartate / metabolism
  • Neurons / pathology
  • Phosphorylation
  • PrPC Proteins / genetics
  • PrPC Proteins / metabolism
  • Prion Diseases / genetics*
  • Prion Diseases / metabolism
  • Prions / genetics*
  • Prions / toxicity*
  • Signal Transduction
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / metabolism
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • PrPC Proteins
  • Prions
  • N-Methylaspartate
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
  • p38 Mitogen-Activated Protein Kinases